Immunohistochemistry Market Detailed Insights and Projections

Meticulous Research® , a global leader in market research, has released a report titled " Immunohistochemistry (IHC) Market Size, Share, Forecast, & Trends Analysis by Offering (Reagents [Fixation, Buffer, Blocking, Antibodies], Kits, Equipment [Staining, Imaging] Method (ABC, CSA, PAP) Process, Application, End User—Global Forecast to 2031."

The global immunohistochemistry market is forecasted to reach $4.08 billion by 2031, with a CAGR of 7.2% from 2024 to 2031. Key drivers of this growth include the rise in chronic diseases, a growing aging population, increased focus on rare diseases, better awareness of early diagnosis, rising R&D investments, drug discovery and development growth, increasing prevalence of infectious diseases, and higher healthcare expenditures.

The market also stands to benefit from trends such as personalized medicine, advancements in genomics and proteomics, and growing automation in immunohistochemistry. However, challenges such as strict technical requirements, complex regulatory processes, and the presence of alternative technologies could affect market growth.

Major Industry Players

Key participants in the immunohistochemistry market include F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (U.S.), Agilent Technologies, Inc. (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), Eagle Biosciences, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Cell Signaling Technology, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Bio SB Inc. (U.S.), Biocare Medical, LLC (U.S.), Bio-Genex Laboratories (U.S.), CANDOR Bioscience GmbH (Germany), and Innovex Biosciences Inc. (U.S.).

Market Breakdown

The immunohistochemistry market is segmented by Offering (Consumables [Reagents {Fixation Reagents, Antigen Retrieval, Buffers, Blocking Reagents, Antibodies, Control Reagents, Chromogenic Substrates, and Counterstain}, and Other Accessories], Equipment [Staining Systems, Imaging Systems, Slide Scanners, and Tissue Microarrays], and Services & Software), Method (Avidin-Biotin Complex, Polymer-Based Immunohistochemistry, Catalyzed Signal Amplification [CSA], Fluorescyl-tyramide Amplification, Improved Catalyzed Signal Amplification [iCSA], Multi-Staining Immunohistochemistry, Labeled Streptavidin Biotin [LSAB], and PAP Method), Process (Sample Preparation, Antigen Retrieval, Background Blocking, Target Detection, and Sample Visualization), Application (Research Applications [Drug Discovery, Agriculture & Animal Research, and Other Applications], and Clinical Applications [Reproductive Health, Oncology, Infectious Disease, and Other Clinical Applications]), End User (Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Academic Institutes & Research Centers, and Other End Users), and Geography. This comprehensive study includes a global and regional market analysis and competitive landscape.

The consumables segment is expected to lead the market in 2024, due to advancements in IHC consumables, the benefits of IHC kits and reagents, and the frequent use of consumables.

The avidin-biotin complex method is forecasted to dominate in 2024, thanks to its high biotin affinity, resistance to enzymatic reactions, and stability under different pH levels.

Clinical applications are projected to hold the largest market share in 2024, with a focus on reproductive health, oncology, and infectious diseases, driven by the rising prevalence of chronic diseases and the growing emphasis on early diagnosis.

Hospitals and diagnostic laboratories are anticipated to be the largest end-user segment in 2024, due to the expansion of healthcare facilities, the presence of advanced systems, and a skilled workforce.

Regional Analysis

The report analyzes key regions including North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Rest of Latin America), and the Middle East & Africa.

Asia-Pacific is expected to experience the highest CAGR during the forecast period, driven by rapid urbanization, increased focus on infectious diseases, and significant investments in healthcare infrastructure.

Download Sample Report Here @  https://www.meticulousresearch.com/download-sample-report/cp_id=5967

Key questions answered in the report:

• Which are the high-growth market segments in terms of offerings, method, application, end user, and region/country?
• What was the historical market size for immunohistochemistry globally?
• What are the market forecasts and estimates for the period 2024–2031?
• What are the major drivers, restraints, challenges, opportunities, and trends in the immunohistochemistry market?
• Who are the major players in the global immunohistochemistry market?
• What is the competitive landscape like, and who are the market leaders in the global immunohistochemistry market?
• What are the recent developments in the global immunohistochemistry market?
• What are the different strategies adopted by the major players in the global immunohistochemistry market?
• What are the geographical trends and high-growth regions/countries?

Contact Us:
Meticulous Research®
Email-  sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn-  https://www.linkedin.com/company/meticulous-research